Wolters Kluwer and DoseMeRx; presentations by Kristi Kuper, PharmD, BCPS, FIDSA, CMWA, and Steve Mok, PharmD, BCPS, BCIDP

Goals: Discuss the complexity of AUC dosing workflows and the benefits of Bayesian dosing for vancomycin, Explore how pharmacy teams are adopting Bayesian dosing tools to streamline workflows, allow automated access to faster, more precise calculations, and proactively monitor therapy to reduce a patient’s risk of acute kidney injury (AKI), Discover best practices for standardizing care with a data-driven approach to dose optimization and keeping prescribing in line with your hospital’s antimicrobial stewardship goals and the CDC’s Core Elements, Demonstrate how with a single click, pharmacists can automatically calculate patient specific vancomycin dose recommendations to achieve a target AUC using key clinical data such as patient demographics,, laboratory values, and previous vancomycin doses given.